A Study of IBI363 in Subjects With Advanced Malignancies

Clinical trial NCT06468098 · RECRUITING

Trial details

NCT number: NCT06468098
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2024-06-15
Primary completion: 2025-06-30
Enrollment: 556

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.